ARTICLE | Clinical News
Influenza DNA vaccine: Preliminary Phase I data
July 21, 2008 7:00 AM UTC
Preliminary data from a double-blind, placebo-controlled, U.S. Phase I trial in 100 healthy volunteers showed that the company's influenza vaccines were well tolerated and achieved potentially protect...